Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03743571 · ClinicalTrials.gov registry record · NA
Augmenting Exposure Therapy for Social Anxiety With Transcranial Direct Current Stimulation
A NA study, sponsored by University of Nevada, Reno.
- Terminated
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT03743571 is a NA study that was terminated before completion, run by University of Nevada, Reno. The registered enrollment target is 33 participants.
The verdict
NCT03743571, a NA study, was terminated before completion, sponsored by University of Nevada, Reno.
- TERMINATED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
This study will examine whether transcranial direct current stimulation (tDCS) can be used to improve outcomes from exposure therapy for social anxiety disorder, and facilitate extinction of fear responding toward individuals outside one's own ethnic group (i.e., ethnic out-group members).
Interventions
- DEVICE transcranial direct current stimulation
- BEHAVIORAL exposure therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2019-04-02 |
| Est. Completion | 2020-03-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03743571
The ClinicalTrials.gov registry entry for NCT03743571 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nevada, Reno, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which transcranial direct current stimulation is the first listed.
NCT03743571 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03743571 about?
NCT03743571 is a clinical study titled "Augmenting Exposure Therapy for Social Anxiety With Transcranial Direct Current Stimulation". This study will examine whether transcranial direct current stimulation (tDCS) can be used to improve outcomes from exposure therapy for social anxiety disorder, and facilitate extinction of fear responding toward individuals outside one's own ethnic group (i.e., ethnic out-group members).
What is the current status of trial NCT03743571?
This trial is currently terminated. It is a NA study. The enrollment target is 33 participants. The study started on 2019-04-02. Estimated completion is 2020-03-05.
What interventions are being tested in trial NCT03743571?
The interventions under investigation include: transcranial direct current stimulation (DEVICE), exposure therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03743571?
This trial is sponsored by University of Nevada, Reno, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.